Research Questions
|
I. What is the overall efficacy of microdosing 1P-LSD in mitigating the symptoms of ASD?
II. What is the maximum drug dosage that will not induce a hallucinogenic effect?
III. How does 1P-LSD influence overexcitation of NMDA receptors?
II. What is the maximum drug dosage that will not induce a hallucinogenic effect?
III. How does 1P-LSD influence overexcitation of NMDA receptors?
Aims
Aim 1: To contribute to the rapidly growing literature of psychedelic research by providing conclusive scientific evidence for the reevaluation of American drug policy.
Aim 2: To lay the foundation for future potential human subjects research studies by determining the efficacy and toxicity of the proposed treatment model in vivo.
Aim 3: To work towards a treatment for social anxiety associated with ASD.
Aim 2: To lay the foundation for future potential human subjects research studies by determining the efficacy and toxicity of the proposed treatment model in vivo.
Aim 3: To work towards a treatment for social anxiety associated with ASD.